Neurocrine Biosciences (NBIX) Goodwill (2022 - 2026)

Neurocrine Biosciences (NBIX) posted quarterly Goodwill of $500.6 million for Q2 2026, up 8243.33% on a QoQ basis from $6.0 million in Q1 2026.

Neurocrine Biosciences (NBIX) Goodwill (2022 - 2026) Analysis & Trends

Neurocrine Biosciences has reported Goodwill for 5 years, with the latest figure at $500.6 million in Q2 2026.

Goodwill for Q2 2026 came in at $500.6 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $500.6 million (changed N/A YoY), and the FY2025 annual result was $6.1 million, up 7.02% from the prior year.
Goodwill rose to $500.6 million in Q2 2026, from $6.0 million in the prior quarter.
Over five years, Goodwill peaked at $500.6 million in Q2 2026 and troughed at $5.4 million in Q4 2022.
A 5-year average of $47.0 million and a median of $5.7 million in 2023 frame the typical range for Goodwill.
The largest YoY upside for Goodwill was 10.91% in 2024 against a maximum downside of 1.72% in 2024.
A 5-year view of Goodwill shows it stood at $5.4 million in 2022, then rose by 7.41% to $5.8 million in 2023, then declined by 1.72% to $5.7 million in 2024, then rose by 7.02% to $6.1 million in 2025, then soared by 8106.56% to $500.6 million in 2026.
Per Business Quant data, the three most recent Goodwill figures were $500.6 million in Q2 2026, $6.0 million in Q1 2026, and $6.1 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-
2	Teva Pharmaceutical Industries	43.42 Bn	39.76 Bn	2.15 Bn
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.77 Bn	22.98 Bn	5.10 Bn
5	United Therapeutics	22.29 Bn	19.63 Bn	683.80 Mn
6	Viatris	18.78 Bn	17.89 Bn	1.46 Bn
7	Neurocrine Biosciences	15.66 Bn	15.27 Bn	935.80 Mn
8	Elanco Animal Health	11.91 Bn	11.38 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-
10	Alkermes	8.20 Bn	7.55 Bn	397.90 Mn

Download Data